182 related articles for article (PubMed ID: 24553243)
1. Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.
Li C; Chacko AM; Hu J; Hasegawa K; Swails J; Grasso L; El-Deiry WS; Nicolaides N; Muzykantov VR; Divgi CR; Coukos G
Cancer Biol Ther; 2014 Apr; 15(4):443-51. PubMed ID: 24553243
[TBL] [Abstract][Full Text] [Related]
2. Development of 124I immuno-PET targeting tumor vascular TEM1/endosialin.
Chacko AM; Li C; Nayak M; Mikitsh JL; Hu J; Hou C; Grasso L; Nicolaides NC; Muzykantov VR; Divgi CR; Coukos G
J Nucl Med; 2014 Mar; 55(3):500-507. PubMed ID: 24525208
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation and Dosimetry of [
Cicone F; Denoël T; Gnesin S; Riggi N; Irving M; Jakka G; Schaefer N; Viertl D; Coukos G; Prior JO
Mol Imaging Biol; 2020 Aug; 22(4):979-991. PubMed ID: 31993928
[TBL] [Abstract][Full Text] [Related]
4. Development, optimization, and validation of novel anti-TEM1/CD248 affinity agent for optical imaging in cancer.
Li C; Wang J; Hu J; Feng Y; Hasegawa K; Peng X; Duan X; Zhao A; Mikitsh JL; Muzykantov VR; Chacko AM; Pryma DA; Dunn SM; Coukos G
Oncotarget; 2014 Aug; 5(16):6994-7012. PubMed ID: 25051365
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TEM1/endosialin in human and murine brain tumors.
Carson-Walter EB; Winans BN; Whiteman MC; Liu Y; Jarvela S; Haapasalo H; Tyler BM; Huso DL; Johnson MD; Walter KA
BMC Cancer; 2009 Nov; 9():417. PubMed ID: 19948061
[TBL] [Abstract][Full Text] [Related]
6. Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.
Facciponte JG; Ugel S; De Sanctis F; Li C; Wang L; Nair G; Sehgal S; Raj A; Matthaiou E; Coukos G; Facciabene A
J Clin Invest; 2014 Apr; 124(4):1497-511. PubMed ID: 24642465
[TBL] [Abstract][Full Text] [Related]
7. Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248.
Bagley RG; Rouleau C; St Martin T; Boutin P; Weber W; Ruzek M; Honma N; Nacht M; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Mol Cancer Ther; 2008 Aug; 7(8):2536-46. PubMed ID: 18723498
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of new TEM1 targeting recombinant antibodies for radioimmunotherapy: In vitro, in vivo and in silico studies.
D'Onofrio A; Gano L; Melo R; Mendes F; Oliveira MC; Denoël T; Schaefer N; Viertl D; Fierle J; Coukos G; Dunn S; Prior JO; Paulo A
Eur J Pharm Biopharm; 2021 Jan; 158():233-244. PubMed ID: 33271301
[TBL] [Abstract][Full Text] [Related]
9. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
Guo Y; Hu J; Wang Y; Peng X; Min J; Wang J; Matthaiou E; Cheng Y; Sun K; Tong X; Fan Y; Zhang PJ; Kandalaft LE; Irving M; Coukos G; Li C
Eur J Cancer; 2018 Feb; 90():111-121. PubMed ID: 29304474
[TBL] [Abstract][Full Text] [Related]
10. Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.
Rybinski K; Imtiyaz HZ; Mittica B; Drozdowski B; Fulmer J; Furuuchi K; Fernando S; Henry M; Chao Q; Kline B; Albone E; Wustner J; Lin J; Nicolaides NC; Grasso L; Zhou Y
Oncotarget; 2015 Sep; 6(28):25429-40. PubMed ID: 26327620
[TBL] [Abstract][Full Text] [Related]
11. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium.
MacFadyen JR; Haworth O; Roberston D; Hardie D; Webster MT; Morris HR; Panico M; Sutton-Smith M; Dell A; van der Geer P; Wienke D; Buckley CD; Isacke CM
FEBS Lett; 2005 May; 579(12):2569-75. PubMed ID: 15862292
[TBL] [Abstract][Full Text] [Related]
12. Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression.
Pierini S; Mishra A; Perales-Linares R; Uribe-Herranz M; Beghi S; Giglio A; Pustylnikov S; Costabile F; Rafail S; Amici A; Facciponte JG; Koumenis C; Facciabene A
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33563772
[TBL] [Abstract][Full Text] [Related]
13. Endosialin: molecular and functional links to tumor angiogenesis.
Kontsekova S; Polcicova K; Takacova M; Pastorekova S
Neoplasma; 2016; 63(2):183-92. PubMed ID: 26774137
[TBL] [Abstract][Full Text] [Related]
14. Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform.
Zhao A; Nunez-Cruz S; Li C; Coukos G; Siegel DL; Scholler N
J Immunol Methods; 2011 Jan; 363(2):221-32. PubMed ID: 20837020
[TBL] [Abstract][Full Text] [Related]
15. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.
Tomkowicz B; Rybinski K; Foley B; Ebel W; Kline B; Routhier E; Sass P; Nicolaides NC; Grasso L; Zhou Y
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):17965-70. PubMed ID: 17986615
[TBL] [Abstract][Full Text] [Related]
16. A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Diaz LA; Coughlin CM; Weil SC; Fishel J; Gounder MM; Lawrence S; Azad N; O'Shannessy DJ; Grasso L; Wustner J; Ebel W; Carvajal RD
Clin Cancer Res; 2015 Mar; 21(6):1281-8. PubMed ID: 25398449
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of the mouse Tem1/endosialin gene regulated by cell density in vitro and expressed in normal tissues in vivo.
Opavsky R; Haviernik P; Jurkovicova D; Garin MT; Copeland NG; Gilbert DJ; Jenkins NA; Bies J; Garfield S; Pastorekova S; Oue A; Wolff L
J Biol Chem; 2001 Oct; 276(42):38795-807. PubMed ID: 11489895
[TBL] [Abstract][Full Text] [Related]
18. Shikonin-loaded antibody-armed nanoparticles for targeted therapy of ovarian cancer.
Matthaiou EI; Barar J; Sandaltzopoulos R; Li C; Coukos G; Omidi Y
Int J Nanomedicine; 2014; 9():1855-70. PubMed ID: 24790428
[TBL] [Abstract][Full Text] [Related]
19. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
20. Mouse endosialin, a C-type lectin-like cell surface receptor: expression during embryonic development and induction in experimental cancer neoangiogenesis.
Rupp C; Dolznig H; Puri C; Sommergruber W; Kerjaschki D; Rettig WJ; Garin-Chesa P
Cancer Immun; 2006 Jul; 6():10. PubMed ID: 16875435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
